Long-term effects of azathioprine therapy for juvenile rheumatoid arthritis

Journal of the Formosan Medical Association

Volumn 99, Issue 4, 2000, Pages 330-335

  Lin, Y T ^a   Yang, Y H ^a   Tsai, M J ^a   Chiang, B L ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Azathioprine; Efficacy; Juvenile rheumatoid arthritis; Side effects

Indexed keywords

ANTIRHEUMATIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GOLD; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; JUVENILE RHEUMATOID ARTHRITIS; MALE; MEDICAL RECORD; PANCYTOPENIA; PRESCHOOL CHILD; REMISSION; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; AZATHIOPRINE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; METHOTREXATE; RETROSPECTIVE STUDIES;

EID: 0033847709     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Slow acting antirheumatic drugs in patients with juvenile rheumatoid arthritis - Evaluated in a randomized, parallel 50-week clinical trial
2. Slow-acting antirheumatic drugs in chronic arthritis of childhood
3. Juvenile rheumatoid arthritis: Outcome and treatment for the 1990s
4. Aggressive therapy for childhood rheumatic diseases. When are immunosuppressives appropriate?
5. Azathioprine in rheumatoid arthritis
6. Azathioprine in rheumatoid arthritis. A double-blind, cross over study
7. Azathioprine in rheumatoid arthritis: A long-term follow-up study
8. Long-term azathioprine in rheumatoid arthritis: A double-blind study
9. Azathioprine in rheumatoid arthritis: Double-blind study of full versus half doses versus placebo
10. Current status of the medical treatment of children with juvenile rheumatoid arthritis
11. Immunosuppressive therapy in children. First experience with azathioprine (Imuran) in Still's disease and rheumatoid arthritis
12. Bone marrow damage following immunosuppressive therapy with azathioprine of juvenile rheumatoid arthritis and Still's disease
13. The treatment of juvenile rheumatoid arthritis with azathioprine
14. Azathioprine versus placebo in patients with juvenile rheumatoid arthritis: A single center double blind comparative study
15. Slow-acting antirheumatic drug use in systemic onset juvenile chronic arthritis
16. Azathioprine in patients with juvenile chronic arthritis: A long term follow up study
17. Current proposed revision of JRA criteria
18. Immunosuppressive and cytotoxic chemotherapy: Long-term complications
19. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment
20. Neoplastic lymphoproliferation in autoimmune disease: An updated review
21. Comparative controlled trial of low-dose weekly methotrexate versus azathioprine in rheumatoid arthritis: 3-Year prospective study
22. Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty-eight-week randomized, double-blind trial
23. Comparison of azathioprine, methotrexate, and the combination of the two in the treatment of rheumatoid arthritis. A forty-eight-week controlled clinical trial with radiologic outcome assessment
24. Efficacy and safety of methotrexate therapy for juvenile rheumatoid arthritis